These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 26244400)

  • 1. An implementation model for scaling up oral pre-exposure prophylaxis in Kenya:
    Were D; Musau A; Mugambi M; Plotkin M; Kabue M; Manguro G; Forsythe S; Glabius R; Mutisya E; Dotson M; Curran K; Reed J
    Gates Open Res; 2021; 5():113. PubMed ID: 34988373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks.
    Zhang L; Herrera C; Coburn J; Olejniczak N; Ziprin P; Kaplan DL; LiWang PJ
    ACS Biomater Sci Eng; 2017; 3(8):1654-1665. PubMed ID: 33225060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US Guidelines That Empower Women to Prevent HIV With Preexposure Prophylaxis.
    Raifman J; Sherman SG
    Sex Transm Dis; 2018 Jun; 45(6):e38-e39. PubMed ID: 29750776
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing HIV in women--still trying to find their VOICE.
    Saag MS
    N Engl J Med; 2015 Feb; 372(6):564-6. PubMed ID: 25651251
    [No Abstract]   [Full Text] [Related]  

  • 5. Preexposure prophylaxis for HIV infection.
    Siemieniuk RA; Bogoch II
    N Engl J Med; 2015 Apr; 372(18):1767-8. PubMed ID: 25923561
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-exposure prophylaxis in women fails to prevent HIV infection in African study.
    Mayor S
    BMJ; 2015 Feb; 350():h717. PubMed ID: 25663035
    [No Abstract]   [Full Text] [Related]  

  • 7. The introduction of new antiretroviral-based HIV prevention methods into health systems: an update.
    Daly F
    Reprod Health Matters; 2012 Jun; 20(39):215. PubMed ID: 22789099
    [No Abstract]   [Full Text] [Related]  

  • 8. Study halted: no benefit seen from antiretroviral pill in preventing HIV in women.
    Stephenson J
    JAMA; 2011 May; 305(19):1952. PubMed ID: 21586708
    [No Abstract]   [Full Text] [Related]  

  • 9. VOICE reveals the need to improve adherence in PrEP trials.
    Tobin SC
    AIDS; 2015 Jul; 29(12):N9. PubMed ID: 26244400
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre-exposure prophylaxis (PrEP) in HIV-uninfected individuals with high-risk behaviour.
    Nadery S; Geerlings SE
    Neth J Med; 2013; 71(6):295-9. PubMed ID: 23956310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM; Mayer KH
    AIDS Patient Care STDS; 2011 Feb; 25(2):63-71. PubMed ID: 21284497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where next with preexposure prophylaxis?
    Nugent D; Gilson R
    Curr Opin Infect Dis; 2017 Feb; 30(1):44-49. PubMed ID: 27870645
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.